首页> 外文期刊>Peptides: An International Journal >Bolus intravenous injection of obestatin does not change blood pressure level of spontaneously hypertensive rat.
【24h】

Bolus intravenous injection of obestatin does not change blood pressure level of spontaneously hypertensive rat.

机译:静脉注射欧司他丁的剂量不改变自发性高血压大鼠的血压水平。

获取原文
获取原文并翻译 | 示例
       

摘要

Ghrelin, an endogenous ligand for the GH secretagogue receptor, has been shown to decrease arterial pressure. Obestatin, a sibling of ghrelin derived from preproghrelin, opposes several physiological actions of ghrelin. The aim of this study was to determine the effects of bolus intravenous injection of obestatin on blood pressure in spontaneously hypertensive rats. Three different dosages of obestatin (10, 50, and 100 microg/kg) and one dosage of ghrelin (10 microg/kg) were applied. The mean arterial pressure and heart period were continuously recorded for 30 min after injection of drugs. Baroreflex sensitivity was also investigated. In this study, we first demonstrated that intravenous injection of obestatin showed no significant effects on mean blood pressure (10 microg/kg: 113.8+/-2.0 mmHg vs. 114.4+/-1.6 mmHg; 50 microg/kg: 110+/-2.4 mmHg vs. 109+/-3.2 mmHg; 100 microg/kg: 115.9+/-1.5 mmHg vs. 115.8+/-2.4 mmHg; all P>0.05), heart period (10 microg/kg: 184.7+/-3.9 ms vs. 185.5+/-4.1ms; 50 microg/kg: 185.9+/-4.1 ms vs. 193.4+/-4.5 ms; 100 microg/kg: 137.7+/-4.5 ms vs. 143.9+/-5.6 ms; all P>0.05), or baroreflex sensitivity (10 microg/kg: 0.414+/-0.03 ms/mmHg vs. 0.442+/-0.02 ms/mmHg; 50 microg/kg: 0.453+/-0.04 ms/mmHg vs. 0.439+/-0.01 ms/mmHg; 100 microg/kg: 0.398+/-0.02 ms/mmHg vs. 0.401+/-0.01 ms/mmHg; all P>0.05), however, intravenous injection of ghrelin could decrease mean arterial pressure (115.9+/-1.5 mmHg vs. 108.6+/-3.6 mmHg, P<0.01) and increase heart period (132.4+/-2.8 ms vs. 152.6+/-7.4 ms, P<0.05), but did not change baroreflex sensitivity (0.36+/-0.009 ms/mmHg, P>0.05) in spontaneously hypertensive rats.
机译:Ghrelin是GH促分泌素受体的内源性配体,已显示可降低动脉压。 Obestatin是一种前生长素释放肽的生长素释放肽的同胞,它对抗生长素释放肽的几种生理作用。这项研究的目的是确定大剂量静脉注射抑抑素对自发性高血压大鼠血压的影响。分别应用了三种不同剂量的Obestatin(10、50和100 microg / kg)和一种剂量的ghrelin(10 microg / kg)。注射药物后30分钟连续记录平均动脉压和心脏周期。还研究了压力反射敏感性。在这项研究中,我们首先证明了静脉注射抑抑素对平均血压没有显着影响(10 microg / kg:113.8 +/- 2.0 mmHg与114.4 +/- 1.6 mmHg; 50 microg / kg:110 +/- 2.4毫米汞柱与109 +/- 3.2毫米汞柱; 100微克/千克:115.9 +/- 1.5毫米汞柱与115.8 +/- 2.4毫米汞柱;所有P> 0.05),心周期(10微克/千克:184.7 +/- 3.9毫秒与185.5 +/- 4.1毫秒; 50微克/千克:185.9 +/- 4.1毫秒与193.4 +/- 4.5毫秒; 100微克/千克:137.7 +/- 4.5毫秒与143.9 +/- 5.6毫秒;所有P> 0.05)或压力反射敏感性(10 microg / kg:0.414 +/- 0.03 ms / mmHg vs. 0.442 +/- 0.02 ms / mmHg; 50 microg / kg:0.453 +/- 0.04 ms / mmHg vs. 0.439 +/- 0.01 ms / mmHg; 100 microg / kg:0.398 +/- 0.02 ms / mmHg vs.0.401 +/- 0.01 ms / mmHg;所有P> 0.05),但是,静脉注射ghrelin可以降低平均动脉压( 115.9 +/- 1.5 mmHg和108.6 +/- 3.6 mmHg,P <0.01)并增加了心脏周期(132.4 +/- 2.8 ms vs. 152.6 +/- 7.4 ms,P <0.05),但没有改变压力反射敏感性自发性高血压(0.36 +/- 0.009 ms / mmHg,P> 0.05)大鼠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号